Calmsie
Calmsie develops prescription grade Digital Therapeutics (DTx) solutions for children's mental health. We employ conversational AI in the form of videobot avatars coupled with cognitive-behavioral (CBT) therapy to deliver world class, evidence-based mental health support for children suffering from depression, anxiety and behavioral addictions.
The cross-functional team has deep expertise in AI/ML, psychiatry, pharmaceuticals, and commercialization, and is currently verifying the solution in a clinical trial. Calmsie was awarded Med-Tech World Product of the Year 2021 Award and was selected as one of the most promising startups to the Healthcare Lab organized by Roche, and to the NVIDIA Inception Program.
We joined the OVHcloud Startup Program to strengthen our cloud resources and optimally manage our network infrastructure. This allows us to minimize risks in scaling our business, so that we are able to achieve our goals worldwide. The events organised by OVHcloud and the resources the program makes available to us are a great support for us.
Marcin Waryszak, COO & Founder Calmsie